Identification of mutations in the α-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes

Mucopolysaccharidosis type I (MPS-I) is an autosomal recessive genetic disease caused by a deficiency of the lysosomal glycosidase α-L-iduronidase. Hurler (severe), Scheie (mild), and Hurler/Scheie (intermediate) syndromes are clinical subtypes of MPS-I, but it is difficult to distinguish between these subtypes by biochemical measurements. Mutation analysis was undertaken to provide a molecular explanation for the clinical variation seen in MPS-I. Using chemical cleavage and direct PCR sequencing, we have defined four previously undescribed mutations for MPS-I (delG₁₇₀₂, 1060+2t→c, R₈₉Q, and 678-7g→a). R₈₉Q and 678-7g→a were found to be present in 40% of Scheie syndrome alleles. Expression of R₈₉Q demonstrated reduced stability and activity of the mutant protein. The deleterious effect of R89Q may be potentiated by a polymorphism (A₃₆₁T) to produce an intermediate phenotype. 678-7g→a was found to be a mild mutation, since it was present in an index Scheie syndrome patient in combination with a severe allele (W₄₀₂X). This mutation appears to allow a very small amount of normal mRNA to be produced from the allele which is likely to be responsible for the mild clinical phenotype observed. Both the 5′ and 3′ splice site mutations (1060+2t→c and 678-7g→a, respectively) result in high proportions of mature mRNAs containing introns, which has not been observed for other splicing mutations. The frameshift mutation (delG₁₇₀₂) and the 5′ splice site mutation (1060+2t→c) are both thought to be associated with severe MPS-I. The identification of these MPS-I mutations begins to document the expected genetic heterogeneity in MPS-I and provides the first molecular explanations for the broad range of clinical phenotypes observed.